European Innovation Council

Innoventric is an Israeli medical device company specializing in percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company's flagship product is the Trillium™ technology, designed to treat Tricuspid Valve Regurgitation through functional valve replacement using Cross-Caval anchoring and a unique multi-valve design.

MediWound Ltd. is an integrated biopharmaceutical company based in Yavne, Israel, that specializes in developing, manufacturing, and commercializing innovative therapeutic products for severe burns and chronic wounds. Founded in 2000, the company is known for its flagship product, NexoBrid, which is an FDA-approved biopharmaceutical designed for the removal of eschar in adults with deep partial- and full-thickness thermal burns, offering a less invasive alternative to surgical interventions. MediWound also advances other product candidates, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic and hard-to-heal wounds, and MWPC003 for connective tissue disorders. The company aims to address significant unmet medical needs in these areas and improve patient outcomes.

MediWound Ltd. is an integrated biopharmaceutical company based in Yavne, Israel, that specializes in developing, manufacturing, and commercializing innovative therapeutic products for severe burns and chronic wounds. Founded in 2000, the company is known for its flagship product, NexoBrid, which is an FDA-approved biopharmaceutical designed for the removal of eschar in adults with deep partial- and full-thickness thermal burns, offering a less invasive alternative to surgical interventions. MediWound also advances other product candidates, including EscharEx, which has completed Phase II clinical trials for the debridement of chronic and hard-to-heal wounds, and MWPC003 for connective tissue disorders. The company aims to address significant unmet medical needs in these areas and improve patient outcomes.

NanoScent is an Israeli sensor technology startup founded in 2017 that develops nanotechnology-based sensors for real-time detection of hydrogen impurities, gases, and volatile organic compounds. The company focuses on climate tech sensing and offers systems for monitoring hydrogen quality across the supply chain—from production to storage and refueling stations. Its flagship product, VOCID H2Confirm, provides in-line monitoring of hydrogen purity and VOCs with real-time alerts. NanoScent's technology supports applications in safety, quality control, and environmental monitoring. The company is headquartered in Misgav, Israel.

Restore Medical develops a device-based therapy for congestive heart failure. Its product, ContraBand, is a catheter-delivered implant in the pulmonary arteries designed to improve patient quality of life and reduce hospital readmission rates.

Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.

Colospan is a medical device company specializing in colorectal surgery. Founded in 2010, it develops innovative products to prevent anastomotic leaks and diverting colonic stomas during intestinal surgeries.

Innoventric is an Israeli medical device company specializing in percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company's flagship product is the Trillium™ technology, designed to treat Tricuspid Valve Regurgitation through functional valve replacement using Cross-Caval anchoring and a unique multi-valve design.

Healium Medical develops a contactless ultrasound ablation system for atrial fibrillation that enables circumferential pulmonary vein isolation with real-time lesion monitoring. The system uses an over-the-wire catheter with a proprietary ultrasound transducer positioned at the pulmonary vein ostium to deliver rapid, non-contact ablation and provide immediate feedback on lesion formation. The solution aims to simplify the procedure, shorten procedure time, and improve efficacy compared with traditional tissue-contact approaches. Founded in 2017, the company is headquartered in Yokneam Illit, Israel.

Healium Medical develops a contactless ultrasound ablation system for atrial fibrillation that enables circumferential pulmonary vein isolation with real-time lesion monitoring. The system uses an over-the-wire catheter with a proprietary ultrasound transducer positioned at the pulmonary vein ostium to deliver rapid, non-contact ablation and provide immediate feedback on lesion formation. The solution aims to simplify the procedure, shorten procedure time, and improve efficacy compared with traditional tissue-contact approaches. Founded in 2017, the company is headquartered in Yokneam Illit, Israel.

PlasFree develops ClearPlasma, a medical device that modifies human plasma to enhance its coagulating properties. This improves treatment for massive bleeding by removing fibrinolytic proteins that dissolve blood clots. Headquartered in Nazareth, Israel, PlasFree aims to revolutionize bleeding treatment globally.

PlasFree develops ClearPlasma, a medical device that modifies human plasma to enhance its coagulating properties. This improves treatment for massive bleeding by removing fibrinolytic proteins that dissolve blood clots. Headquartered in Nazareth, Israel, PlasFree aims to revolutionize bleeding treatment globally.

Colospan is a medical device company specializing in colorectal surgery. Founded in 2010, it develops innovative products to prevent anastomotic leaks and diverting colonic stomas during intestinal surgeries.

Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.

Innoventric is an Israeli medical device company specializing in percutaneous solutions for Tricuspid Regurgitation and right heart disease. Founded in 2017, the company's flagship product is the Trillium™ technology, designed to treat Tricuspid Valve Regurgitation through functional valve replacement using Cross-Caval anchoring and a unique multi-valve design.

NanoScent is an Israeli sensor technology startup founded in 2017 that develops nanotechnology-based sensors for real-time detection of hydrogen impurities, gases, and volatile organic compounds. The company focuses on climate tech sensing and offers systems for monitoring hydrogen quality across the supply chain—from production to storage and refueling stations. Its flagship product, VOCID H2Confirm, provides in-line monitoring of hydrogen purity and VOCs with real-time alerts. NanoScent's technology supports applications in safety, quality control, and environmental monitoring. The company is headquartered in Misgav, Israel.

HIL Applied Medical is developing a new class of ultra-compact, high-performance accelerators for proton therapy. The company applies a patented approach to particle acceleration and beam delivery, combining nano-technology with ultra-high-intensity lasers and ultra-fast magnets. These advances aim to reduce the size, complexity and cost of proton therapy systems while preserving clinical utility, with the goal of a single-room add-on solution that is truly cost-effective. HIL Applied Medical is a privately held company backed by venture investors and global strategic partners. It is headquartered in the High-Tech Park in Givat Ram, Jerusalem, Israel, and maintains a wholly owned subsidiary in Reno, Nevada.

NanoScent is an Israeli sensor technology startup founded in 2017 that develops nanotechnology-based sensors for real-time detection of hydrogen impurities, gases, and volatile organic compounds. The company focuses on climate tech sensing and offers systems for monitoring hydrogen quality across the supply chain—from production to storage and refueling stations. Its flagship product, VOCID H2Confirm, provides in-line monitoring of hydrogen purity and VOCs with real-time alerts. NanoScent's technology supports applications in safety, quality control, and environmental monitoring. The company is headquartered in Misgav, Israel.

Polymertal Ltd is an innovative company based in Haifa, Israel, specializing in advanced metal plating processes that enable the production of lightweight hybrid metal-polymer components. Founded in 2007, Polymertal serves a diverse range of industries, including defense, communications, aviation, and space. The company offers a comprehensive suite of products and solutions, such as hybrid components, electronic cases, hybrid molds, and hybrid RF elements. Its proprietary technology allows for the effective bonding of metals and polymers, making it possible to replace traditional metal parts with cost-effective hybrid alternatives, even in critical applications. Additionally, Polymertal provides plating services and 3D object surface smoothing to enhance the performance and functionality of its products.

Founded in 2018, Indoor Robotics designs and develops Tando, an AI-powered patrol drone for indoor security and inspection missions. Its unique features include independent AI-based navigation and patented ceiling docking, providing real-time coverage with predictive analysis to minimize false alarms.

MeMed Diagnostics Ltd. is a personalized diagnostics company founded in 2009 and headquartered in Tirat Carmel, Israel. The company specializes in developing innovative diagnostic solutions to enhance patient care and reduce healthcare costs by providing rapid and actionable insights for infectious diseases. Its flagship product, MeMed BV, is a test designed to distinguish between bacterial and viral infections, while the ImmunoDx platform utilizes proprietary biomarkers and algorithms to analyze patients' immune responses, helping physicians make informed antibiotic treatment decisions. MeMed's technologies aim to mitigate the misuse of antibiotics, which is a significant issue globally, leading to ineffective treatments and the emergence of resistant bacterial strains. By addressing the diagnostic gaps in infectious disease management, MeMed seeks to improve clinical outcomes and promote the responsible use of antibiotics.

OncoHost is a clinical-stage biotechnology company based in Binyamina, Israel, focused on developing personalized strategies to enhance the efficacy of cancer therapies. Founded in 2017, the company leverages proprietary proteomic analysis to gain insights into individual patient responses to treatment, addressing the significant challenge of therapy resistance in oncology. By analyzing proteomic changes in blood samples, OncoHost's platform facilitates the early identification of patients likely to be non-responsive to cancer treatments and aids in discovering new drug targets. This innovative approach combines bioinformatics, systems biology, and machine learning to provide healthcare institutions with critical information regarding predicted clinical benefits from therapies, ultimately enabling the development of tailored treatment strategies that aim to improve patient outcomes and minimize side effects. Through extensive clinical programs in collaboration with leading academic and clinical partners, OncoHost positions itself at the forefront of precision cancer medicine.